Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Kuwahara

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Pharmacology & Therapeutics|April 24, 2021
The natriuretic peptide system in heart failure: Diagnostic and therapeutic implicationsKoichiro Kuwahara
Circulation Journal : Official Journal of the Japanese Circulation Society|October 16, 2013
Role of NRSF/REST in the regulation of cardiac gene expression and functionKoichiro Kuwahara
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 12, 2012
[Ca2+ channels as novel therapeutic targets in heart failure]Koichiro Kuwahara
Endocrine Journal|June 24, 2010
Regulation and significance of atrial and brain natriuretic peptides as cardiac hormonesKoichiro Kuwahara, Kazuwa Nakao
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Regulation of natriuretic peptide gene expression]Koichiro Kuwahara, Kazuwa Nakao
Biology|August 26, 2022
NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and BeyondHideaki Inazumi, Koichiro Kuwahara
Journal of Pharmacological Sciences|July 16, 2011
New molecular mechanisms for cardiovascular disease:transcriptional pathways and novel therapeutic targets in heart failureKoichiro Kuwahara, Kazuwa Nakao
Journal of Cardiology|April 29, 2020
Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patientsYasuaki Nakagawa, Koichiro Kuwahara
Pharmacology & Therapeutics|February 10, 2015
The organ-protective effect of N-type Ca(2+) channel blockadeKoichiro Kuwahara, Takeshi Kimura
Journal of Cardiology|November 14, 2022
Periprocedural myocardial infarction in patients undergoing percutaneous coronary interventionYasushi Ueki, Koichiro Kuwahara
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Pharmacology & Therapeutics|April 24, 2021
The natriuretic peptide system in heart failure: Diagnostic and therapeutic implicationsKoichiro Kuwahara
Circulation Journal : Official Journal of the Japanese Circulation Society|October 16, 2013
Role of NRSF/REST in the regulation of cardiac gene expression and functionKoichiro Kuwahara
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 12, 2012
[Ca2+ channels as novel therapeutic targets in heart failure]Koichiro Kuwahara
Endocrine Journal|June 24, 2010
Regulation and significance of atrial and brain natriuretic peptides as cardiac hormonesKoichiro Kuwahara, Kazuwa Nakao
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Regulation of natriuretic peptide gene expression]Koichiro Kuwahara, Kazuwa Nakao
Biology|August 26, 2022
NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and BeyondHideaki Inazumi, Koichiro Kuwahara
Journal of Pharmacological Sciences|July 16, 2011
New molecular mechanisms for cardiovascular disease:transcriptional pathways and novel therapeutic targets in heart failureKoichiro Kuwahara, Kazuwa Nakao
Journal of Cardiology|April 29, 2020
Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patientsYasuaki Nakagawa, Koichiro Kuwahara
Pharmacology & Therapeutics|February 10, 2015
The organ-protective effect of N-type Ca(2+) channel blockadeKoichiro Kuwahara, Takeshi Kimura
Journal of Cardiology|November 14, 2022
Periprocedural myocardial infarction in patients undergoing percutaneous coronary interventionYasushi Ueki, Koichiro Kuwahara
Pageof 31